GSK2190915
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for GSK2190915, covering 2013-08-21 to 2018-03-01. Get the full timeline:
Most recent: Clinical Trial Update: GSK2190915 Moderate to Severe Asthma Study [Phase 2]